SWS Hemodialysis Care Co., Ltd. (SHA:688410)
12.88
+0.08 (0.63%)
At close: Apr 25, 2025, 2:57 PM CST
SWS Hemodialysis Care Revenue
SWS Hemodialysis Care had revenue of 189.26M CNY in the quarter ending March 31, 2025, with 16.77% growth. This brings the company's revenue in the last twelve months to 594.45M, down -9.82% year-over-year. In the year 2024, SWS Hemodialysis Care had annual revenue of 567.27M, down -17.80%.
Revenue (ttm)
594.45M
Revenue Growth
-9.82%
P/S Ratio
6.72
Revenue / Employee
539.43K
Employees
881
Market Cap
3.99B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 567.27M | -122.84M | -17.80% |
Dec 31, 2023 | 690.11M | 308.10M | 80.65% |
Dec 31, 2022 | 382.01M | 98.74M | 34.85% |
Dec 31, 2021 | 283.28M | 28.87M | 11.35% |
Dec 31, 2020 | 254.41M | 112.10M | 78.78% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |
Shanghai United Imaging Healthcare | 10.30B |